Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy

Mogamulizumab induces cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity in advanced cutaneous T-cell lymphoma patients. Since the efficacy of mogamulizumab in mycosis fungoides (28.6%) is lower than that in Sézary syndrome (47.1%), reagents that enhance the a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Oncol
Autors principals: Fujimura, Taku, Tanita, Kayo, Sato, Yota, Kambayashi, Yumi, Furudate, Sadanori, Tsukada, Akira, Hashimoto, Akira, Aiba, Setsuya
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5836287/
https://ncbi.nlm.nih.gov/pubmed/29515406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486278
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars